Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 11;16(4):364–373. doi: 10.1159/000530174

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Author(s). Published by S. Karger AG, Basel

This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.

PMC Copyright notice

Fig. 3. — Comparison of the proportion of natural killer cells (NK cells) in all CD3⁻ lymphocytes (a), CD57⁺ NK cells (b), CD56^bright NK cells (c), CD56^dim/neg NK cells (d) in all NK cells before LVAD implantation and in the FU period in normal-weight, pre-obese, and obese patients. *p ≤ 0.05 compared to the pre-operative value of the same group. #p ≤ 0.05 compared to normal-weight patients in the same period. Measurement dates comprise the time prior to LVAD implantation (pre-op), after 3 months (1st FU), after 6 months (2nd FU), and after 12 months (3rd FU). BMI, body mass index; CD, cluster of differentiation; FU, follow-up.